Bimetinib Intermediate
have 0 Relevant products
Bimetinib, Also Known As Mektovi And Ary-162, Is A Small Anti-Cancer Molecule Developed By Array Biopharma For The Treatment Of Various Cancers. Bimetinib Is A Selective Inhibitor Of Mek And A Central Kinase Of Mapk Pathway Promoted By Cancer.
